“Apple has similarly infringed on other companies’ technologies, and we believe today’s ruling exposes Apple as a company that takes other companies’ innovations and repackages them.” – Masimo press release The U.S. International Trade Commission on Tuesday issued a Notice of Final Initial Determination (FID) finding that Apple violated Section 337 of the Tariff Act of 1930 by importing and selling in the United States Apple Watches with light-based pulse oximetry technology that infringed...
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Philip Stevens
Why Voluntary Licensing is Best for Increasing Access to Medicines
“Confrontational approaches such as compulsory licensing are time consuming, risky and an ultimately unsustainable way of addressing global health challenges. Voluntary licensing, by contrast, benefits all stakeholders, especially patients.” When it comes to how to best increase access to medicines in low and middle-income countries (LMICs), compulsory licensing gets most of the attention.
Overriding patents won't help EU Covid jab drive
Friday, 19 March 2021 This is an opinion article by an external contributor. The views belong to the writer. Faced by a mounting crisis with the European Union’s Covid vaccination programmes, Ursula von der Leyen told reporters on Wednesday that “all options are on the table” to speed up Europe’s vaccine rollout. “We are in the crisis of the century. I am not ruling out anything for now because we have to make sure that Europeans are vaccinated as soon as possible,” she said.
Why intellectual property rights are a key, not a curse, for Covid-19 vaccines
The rapid development of new Covid-19 vaccines and treatments over the past year is a triumph of innovation. Billions of vaccine doses are being manufactured and should be distributed to all adults globally over the next 18 months. But health non-governmental organisations (NGOs) and some governments argue that suspending intellectual property (IP) rights to allow unfettered vaccine manufacture will mean faster access for developing countries.
Why intellectual property rights matter for COVID-19
By Philip Stevens and Mark Schultz Summary At every step of the COVID-19 crisis, critics of intellectual property rights (IPRs) have called for their suspension, claiming IPRs will thwart research and development and make vaccines and treatments unaffordable. In reality IPRs have been crucial, promoting trust, knowledge-sharing and collaboration between organisations and individuals.
Rules, Britannia, like it or not
The lesson here is that national sovereignty is illusory when separated from the power to act BL PREMIUM 08 March 2019 - 05:06 Philip Stevens
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Philip
Contact Philip, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack